Comparing Ghrelin Agonists for Stomach Motility: Peptide and Non-Peptide GHS Move the Gut

Both peptide (ghrelin, GHRP-6) and non-peptide (MK-677-related) GH secretagogues stimulated gastric motility in mice, with peptide agonists showing stronger gastroprokinetic effects — confirming gut effects across the GHS drug class.

Kitazawa, T et al.·Gut·2005·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-01056Animal StudyPreliminary Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Both peptide (ghrelin, GHRP-6) and non-peptide GH secretagogues stimulated gastric contractions in mice in vivo and in vitro, with peptide agonists producing stronger gastroprokinetic effects — gut motility stimulation is a class effect of GHS.

Key Numbers

How They Did This

animal-study study on ghrp, gut-healing.

Why This Research Matters

Relevant for ghrp, gut-healing.

The Bigger Picture

Advances peptide research with clinical implications.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Both peptide (ghrelin, GHRP-6) and non-peptide GH secretagogues stimulated gastric contractions in mice in vivo and in vitro, with peptide agonists pr
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2005.
Original Title:
Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro.
Published In:
Gut, 54(8), 1078-84 (2005)
Database ID:
RPEP-01056

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Comparing Ghrelin Agonists for Stomach Motility: Peptide and Non-Peptide GHS Move the Gut

What was found?

Both peptide (ghrelin, GHRP-6) and non-peptide (MK-677-related) GH secretagogues stimulated gastric motility in mice, with peptide agonists showing stronger gastroprokinetic effects — confirming gut effects across the GHS drug class.

Read More on RethinkPeptides

Cite This Study

RPEP-01056·https://rethinkpeptides.com/research/RPEP-01056

APA

Kitazawa, T; De Smet, B; Verbeke, K; Depoortere, I; Peeters, T L. (2005). Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro.. Gut, 54(8), 1078-84.

MLA

Kitazawa, T, et al. "Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro.." Gut, 2005.

RethinkPeptides

RethinkPeptides Research Database. "Gastric motor effects of peptide and non-peptide ghrelin ago..." RPEP-01056. Retrieved from https://rethinkpeptides.com/research/kitazawa-2005-gastric-motor-effects-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.